Price
CHART BY
Frequently asked questions
What is Cerus Corp's market capitalization?
The market capitalization of Cerus Corp is $306.43M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Cerus Corp?
Cerus Corp's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.114. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Cerus Corp's stock?
Currently, 6 analysts cover Cerus Corp's stock, with a consensus target price of $3.90. Analyst ratings provide insights into the stock's expected performance.
What is Cerus Corp's revenue over the trailing twelve months?
Over the trailing twelve months, Cerus Corp reported a revenue of $186.21M.
What is the EBITDA for Cerus Corp?
Cerus Corp's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$26.71M. EBITDA measures the company's overall financial performance.
What is the free float of Cerus Corp's shares?
The free float of Cerus Corp is 176.30M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $306.43M
- EPS (TTM)
- -$0.114
- Free Float
- 176.30M
- Revenue (TTM)
- $186.21M
- EBITDA (TTM)
- -$26.71M
Pricing
- 1D span
- $1.59$1.925
- 52W span
- $1.375$2.585
Analyst Ratings
The price target is $3.90 and the stock is covered by 6 analysts.
Buy
4
Hold
2
Sell
0
Information
Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- US1570851014
- Primary Ticker
- CERS
Knockouts
Finance data from FactSet